Skip to search formSkip to main contentSkip to account menu

iodine-131-tositumomab

Known as: I 131 Monoclonal Antibody Anti-B1, tositumomab iodine i 131, Iodine I 131 Monoclonal Antibody Anti-B1 
A monoclonal antibody (tositumomab) that has been chemically changed by adding radioactive iodine, and that is used in the treatment of certain types… 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (2)

Antineoplastic AgentsMonoclonal Antibodies

Narrower (1)

Bexxar
Human B-Lymphocyte Antigen CD20, humanNCIt Antineoplastic Agent TerminologyTositumomab and Iodine I 131 Tositumomab Therapytositumomab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy.
UNLABELLED A methodology was developed determining patient releasability after radioimmunotherapy with tositumomab and (131)I… 
2000
2000
Iodine I 131 Tositumomab for Patients With Follicular Non-Hodgkin’s Lymphoma (NHL): Overall Clinical Trial Experience by Histology
Iodine-131 tositumomab (Bexxar) is a new radioimmunotherapy in development for the treatment of patients with low-grade or… 
Review
1999
Review
1999
Lymphoid aggregates in bone marrow mimic residual lymphoma after rituximab therapy for non-Hodgkin lymphoma.
Rituximab is a novel anti-CD20 monoclonal antibody used in the treatment of relapsed low-grade non-Hodgkin lymphoma. To determine… 
1999
1999
Efficacy of iodine-131 6β-methyl-iodo-19-norcholesterol scintigraphy and computed tomography in patients with primary aldosteronism
Abstract. In order to define the role of scintigraphy in determining the aetiology of primary aldosteronism, 41 patients were… 
1998
1998
Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapy.
UNLABELLED The expected effective dose equivalent to an individual from contact with 131I anti-B1 radioimmunotherapy (RIT… 
Review
1998
Review
1998
Revised Nuclear Regulatory Commission regulations for release of patients administered radioactive materials: outpatient iodine-131 anti-B1 therapy.
UNLABELLED The Nuclear Regulatory Commission regulations for the release of patients administered radioactive material have been… 
1988
1988
Conjugate view gamma camera method for estimating tumor uptake of iodine-131 metaiodobenzylguanidine.
Therapy with [131I]MIBG has produced partial remissions of malignant pheochromocytomas but not all patients respond. Responses… 
1985
1985
Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.
A 29-yr-old woman with systemic lupus erythematosus (SLE) was found to have no detectable C3b/C4b receptors (CR1) on her… 
1984
1984
Characterization of immature sinus histiocytes (monocytoid cells) in reactive lymph nodes by use of monoclonal antibodies.
1981
1981
Cross-reactivity between C-reactive protein and idiotypic determinants on A phosphocholine-binding murine myeloma protein
Binding of human 125I-C-reactive protein (CRP) to sheep erythrocytes sensitized with pneumococcal C polysaccharide (E-PnC) was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)